These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 14100237)
41. MAPLE SYRUP URINE DISEASE. REPORT OF TWO CASES. LONSDALE D; MERCER RD; FAULKNER WR Am J Dis Child; 1963 Sep; 106():258-66. PubMed ID: 14057605 [No Abstract] [Full Text] [Related]
42. [Dietetics in hereditary enzyme deficiencies]. Royer P Sem Hop; 1970 Feb; 46(10):653-9. PubMed ID: 4314674 [No Abstract] [Full Text] [Related]
43. Prospective study of maple-syrup-urine disease for the first four days of life. DiGeorge AM; Rezvani I; Garibaldi LR; Schwartz M N Engl J Med; 1982 Dec; 307(24):1492-5. PubMed ID: 7144815 [No Abstract] [Full Text] [Related]
45. [Maple Syrup Urine Disease in a newborn infant]. Mazur A; Sykut-Cegielska J; Ciebiera M; Trzeciak J; Taybert J; Kowalik A; Ołtarzewski M Med Wieku Rozwoj; 2007; 11(1):65-8. PubMed ID: 17965467 [TBL] [Abstract][Full Text] [Related]
46. Dermatitis in treated maple syrup urine disease. Koch SE; Packman S; Koch TK; Williams ML J Am Acad Dermatol; 1993 Feb; 28(2 Pt 2):289-92. PubMed ID: 8436640 [TBL] [Abstract][Full Text] [Related]
47. Maple syrup urine disease. Two cases in Israel. Chemke J; Levin S Isr J Med Sci; 1975 Aug; 11(8):809-16. PubMed ID: 1165176 [TBL] [Abstract][Full Text] [Related]
48. Corneal deepithelialization caused by acute deficiency of isoleucine during treatment of a patient with maple syrup urine disease. Tornqvist K; Tornqvist H Acta Ophthalmol Scand Suppl; 1996; (219):48-9. PubMed ID: 8741119 [TBL] [Abstract][Full Text] [Related]
49. MAPLE SYRUP URINE DISEASE; FURTHER OBSERVATIONS. WOODY NC; HANCOCK CD Am J Dis Child; 1963 Dec; 106():578-85. PubMed ID: 14063708 [No Abstract] [Full Text] [Related]
50. [3 patients with maple syrup urine disease]. Merinero B; del Valle JA; García MJ; García Miguel MJ; Barrio MI; García Hortelano J; Morales E; González F; García Aparicio J; Sáez Pérez E An Esp Pediatr; 1983 Nov; 19(5):393-400. PubMed ID: 6660657 [TBL] [Abstract][Full Text] [Related]
51. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine). Mogoş T; Cheţa CP; Mincu IT Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313 [TBL] [Abstract][Full Text] [Related]
53. An 11-day-old boy with lethargy, poor feeding, vomiting. Maple syrup urine disease. Charrow J Pediatr Ann; 2005 Oct; 34(10):772-4. PubMed ID: 16285630 [No Abstract] [Full Text] [Related]
54. Living related versus deceased donor liver transplantation for maple syrup urine disease. Feier F; Schwartz IV; Benkert AR; Seda Neto J; Miura I; Chapchap P; da Fonseca EA; Vieira S; Zanotelli ML; Pinto e Vairo F; Camelo JS; Margutti AV; Mazariegos GV; Puffenberger EG; Strauss KA Mol Genet Metab; 2016 Mar; 117(3):336-43. PubMed ID: 26786177 [TBL] [Abstract][Full Text] [Related]
55. [Metabolic study of the classic form of leucinosis during exchange transfusion therapy]. Zeman J; Hyánek J; Houstková H; Rubín A; Verner P; Pehal F; Konecná L; Zapadlo M; Plavka R; Wendel U Cesk Pediatr; 1987 Apr; 42(4):219-22. PubMed ID: 3594613 [No Abstract] [Full Text] [Related]
56. [Hereditary metabolic diseases: maple syrup disease]. Berger R; Broyer M Presse Med (1893); 1968 Jul; 76(30):1531-2. PubMed ID: 5686194 [No Abstract] [Full Text] [Related]
57. Cerebral computed tomography in maple syrup urine disease. Romero FJ; Ibarra B; Rovira M; Natal A; Herrera M; Segarra A J Comput Assist Tomogr; 1984 Jun; 8(3):410-1. PubMed ID: 6609940 [TBL] [Abstract][Full Text] [Related]
58. Prolongation of G1 and S phase in C-6 glioma cells treated with maple syrup urine disease metabolits. Morphologic and cell cycle studies. Liao CL; Herman MM; Bensch KG Lab Invest; 1978 Feb; 38(2):122-33. PubMed ID: 564423 [TBL] [Abstract][Full Text] [Related]
59. Maple syrup urine disease. PATRICK AD Arch Dis Child; 1961 Jun; 36(187):269-72. PubMed ID: 13733337 [No Abstract] [Full Text] [Related]